A Novel Method of Determining the Functional Effects of a Minor Genetic Modification of a Protein.

about

A Novel Method of Determining the Functional Effects of a Minor Genetic Modification of a Protein.

Item

http://www.wikidata.org/entity/Q36351116

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A Novel Method of Determining ...... tic Modification of a Protein.

@ast

A Novel Method of Determining ...... tic Modification of a Protein.

@en

type

Item

label

A Novel Method of Determining ...... tic Modification of a Protein.

@ast

A Novel Method of Determining ...... tic Modification of a Protein.

@en

prefLabel

A Novel Method of Determining ...... tic Modification of a Protein.

@ast

A Novel Method of Determining ...... tic Modification of a Protein.

@en

P1476

A Novel Method of Determining ...... tic Modification of a Protein.

@en

P2093

Danuta Szczesna-Cordary

http://www.w3.org/2001/XMLSchema#string

Divya Duggal

http://www.w3.org/2001/XMLSchema#string

Ignacy Gryczynski

http://www.w3.org/2001/XMLSchema#string

Janhavi Nagwekar

http://www.w3.org/2001/XMLSchema#string

Jingsheng Liang

http://www.w3.org/2001/XMLSchema#string

Julian Borejdo

http://www.w3.org/2001/XMLSchema#string

Katarzyna Kazmierczak

http://www.w3.org/2001/XMLSchema#string

Krishna Midde

http://www.w3.org/2001/XMLSchema#string

Rafal Fudala

http://www.w3.org/2001/XMLSchema#string

Ryan Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations

Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy

Use of fluorescence polarization to observe changes in attitude of S-1 moieties in muscle fibers.

Concentration correlation spectroscopy: a new biophysical probe based on occupation number fluctuations.

Familial hypertrophic cardiomyopathy can be characterized by a specific pattern of orientation fluctuations of actin molecules .

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCVM.2015.00035

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284228065

http://www.w3.org/2001/XMLSchema#string

P698

26664906

http://www.w3.org/2001/XMLSchema#string

P932

4671333

http://www.w3.org/2001/XMLSchema#string